BioNTech has launched global clinical trials for BNT116, an mRNA vaccine designed to treat non-small cell lung cancer.

The BioNTech SE ADR BNTX rallied 1.59% to $117.64 Thursday, on what proved to be an all-around favorable trading session for ...

Along with the annual flu vaccine, the new COVID-19 vaccine formulation is now widely available in Minnesota. It comes at a ...

The University of Dundee and NHS Tayside is the first hospital site in Europe to open a trial of a new investigational ...

Free rapid tests for COVID-19 are now available to order online.As of Friday, Sept. 27, every American household may order ...

The Covid booster jab autumn scheme is opening in just a few days with some Brits eligible and encouraged to get their ...

A federal judge has dismissed a lawsuit by a New York family who claimed the Department of Defense misled Americans into ...

The autumn wave of coronavirus is sweeping across Germany. Those affected mainly suffer from coughs, colds, sore throats and ...

We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP ...

The general consensus was that this was all very instructional, as if we had attended a lecture rather than a play.

The company produces vials for mRNA vaccines, diabetes and obesity drugs and counts BioNTech and Moderna among its clients. Schott Pharma has production and sales units across 33 countries. Schott ...